Loading…
Reported covered position: Policy Fellow, NIH/NHGRI Office of the Director
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
Removing Barriers to Colorectal Cancer Screening Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · 1T
Coverage and reimbursement of molecular diagnostics, companion diagnostics at FDA, no bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · 1T
Source: Senate LDA
| SUSAN G. KOMEN |
| 17 |
| 2015–2018 |
| TETHYS BIOSCIENCE | 12 | 2011–2012 |
| COUNSYL | 11 | 2016–2018 |
| DIADEXUS INC | 8 | 2012–2014 |
| ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY | 8 | 2015–2017 |
| CURE FORWARD | 7 | 2015–2017 |
| CRESCENDO BIOSCIENCE INC. | 6 | 2012–2013 |
| NAVIGENICS, INC. | 6 | 2011 |
| PACIFIC BIOSCIENCES, INC. | 6 | 2011 |
| MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) | 5 | 2018–2019 |
| AMGEN, INC. | 4 | 2015 |
| PERSONALIZED MEDICINE COALITION | 3 | 2017 |
| NATERA, INC. | 2 | 2015 |
| THYNC, INC. | 2 | 2015 |
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Cancer Drug Parity Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Cancer Drug Parity Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Cancer Drug Parity Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Cancer Drug Parity Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Consolidated Appropriations Act, 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018 FY 2019 Labor, Health and Human Services and Education Appropriations bill
Consolidated Appropriations Act, 2018
Client: COUNSYL · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1625, Vehicle for Consolidated Appropriations Act 2018 FY 2019, Labor, Health and Human Services and Education Appropriations Act
Consolidated Appropriations Act, 2018
Client: INVITAE, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1625, Vehicle for Consolidated Appropriations Act 2018 FY 2019 Labor, Health and Human Services and Education Appropriations bill
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Local Coverage Determination Clarification Act of 2018
Client: MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
American Competitiveness in Biotechnology Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2018
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2018
Client: MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2018
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Chronic Disease Management Act of 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Chronic Disease Management Act of 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Chronic Disease Management Act of 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Chronic Disease Management Act of 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Advancing Access to Precision Medicine Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Advancing Access to Precision Medicine Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Advancing Access to Precision Medicine Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Advancing Access to Precision Medicine Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Know the Cost Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Know the Cost Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Know the Lowest Price Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Know the Lowest Price Act of 2018
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Patient Right to Know Drug Prices Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Patient Right to Know Drug Prices Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: INVITAE, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: INVITAE, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: INVITAE, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
Client: INVITAE, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Ensuring Coverage for Patients with Pre-Existing Conditions Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Ensuring Coverage for Patients with Pre-Existing Conditions Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Local Coverage Determination Clarification Act of 2017
Client: MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
American Competitiveness in Biotechnology Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2017
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2017
Client: MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Local Coverage Determination Clarification Act of 2017
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Preserving Employee Wellness Programs Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 114-255, 21st Century Cures Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Preserving Employee Wellness Programs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Preserving Employee Wellness Programs Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
Preserving Employee Wellness Programs Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 114-255, 21st Century Cures Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Preserving Employee Wellness Programs Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Medical Foods
Prescription Drug Price Transparency Act
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Patients' Access to Treatment Act, HR 2999 Biosimilar naming, interchangeability Off Label Communications Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Cancer Drug Parity Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
American Health Care Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
American Health Care Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1628 American Health Care Act; Better Care Reconciliation Act
American Health Care Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Medical Foods
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Medical Product Communications Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Patients' Access to Treatment Act, HR 2999 Biosimilar naming, interchangeability Off Label Communications Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
Patients' Access to Treatments Act of 2017
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Patients' Access to Treatment Act, HR 2999 Biosimilar naming, interchangeability Off Label Communications Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Patients' Access to Treatments Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: COUNSYL · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: COUNSYL · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Save Women's Preventive Care Act
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
National Defense Authorization Act for Fiscal Year 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 2810/ S 1519, National Defense Authorization Act
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: COUNSYL · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018
Client: COUNSYL · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Invest in Women's Health Act of 2017
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
Cancer Drug Coverage Parity Act of 2015
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Cancer Drug Coverage Parity Act of 2015
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Genetic Research Privacy Protection Act
Client: 23ANDME, INC. · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Direct to consumer genetic testing Regulation and oversight of diagnostics S. 2744, Genetic Research Privacy Protection Act Public Law No. 44-255 21st Century Cures Act
Preserving Employee Wellness Programs Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Patients' Access to Treatments Act of 2015
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1600 Patient's Access to Treatment Act Biosimilar naming
Patients' Access to Treatments Act of 2015
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1600 Patient's Access to Treatment Act Biosimilar naming Patient Engagement with FDA on medical devices Off Label Communications
Patients' Access to Treatments Act of 2015
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1600 Patient's Access to Treatment Act Biosimilar naming arthritis prevention S. 524, Comprehensive Addiction and Recovery Act of 2016 Reimbursement/coverage of arthritis treatment
Patients' Access to Treatments Act of 2015
Client: GLOBAL HEALTHY LIVING FOUNDATION · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 1600 Patient's Access to Treatment Act Biosimilar naming arthritis prevention
Cancer Drug Coverage Parity Act of 2015
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation; clinical trials issues (FDA); HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Cancer Drug Coverage Parity Act of 2015
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation; clinical trials issues (FDA); HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Cancer Drug Coverage Parity Act of 2015
Client: SUSAN G. KOMEN · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation HR 2739/S 1566 - Cancer Drug Coverage Parity Act
21st Century Cures Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 S. 620/HR. 1189, Preserving Employee Wellness Programs Act
21st Century Cures Act
Client: ASSOCIATION FOR MOLECULAR PATHOLOGY · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
21st Century Cures Act
Client: CURE FORWARD · Firm: CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Precision Medicine Initiative Cancer Moonshot Patient Access to lab Results Regulation of Health Software HR 6 21st Century Cures S. 1101 MEDTECH Act
companion diagnostics at FDA, no bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act, coverage and reimbursement of molecular diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · 1T
Drug Pricing, Medicare Part D, real world evidence
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2019 · first_quarter · 1T
Data Privacy, consumer genomics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Direct to Consumer Genetic Testing American competitiveness in biotechnology; data privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733 Medicare Part B coverage policy Health Reimbursement Arrangements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Reimbursement of diagnostics
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · fourth_quarter · Q4
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Drug Pricing Act, S.2554 Know the Lowest Price Act of 2018, S. 2553 Know the Cost Act of 2018, H.R. 6733
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018 S. 3388 Ensuring Coverage for Patients with Pre-Existing Conditions Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · 3A
Reimbursement of diagnostics
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
American Competitiveness in Biotechnology Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · 3T
Health Disparities
FY 2019, Labor, Health and Human Services and Education Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics Local Coverage Determination Clarification Act of 2018 (HR 3635/S 794)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
Direct to Consumer Genetic Testing American competitiveness in biotechnology; data privacy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · third_quarter · Q3
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Reimbursement of diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
HR 1017, Removing Barriers to Colorectal Cancer Screening Act Clinical Trial Policy
FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Health Disparities
FY 2019, Labor, Health and Human Services and Education Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Reimbursement of diagnostics
FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Direct to Consumer Genetic Testing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · second_quarter · Q2
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act HR 5062, Advancing Access to Precision Medicine Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
H.R. 1625, Vehicle for Consolidated Appropriations Act 2018 FY 2019, Labor, Health and Human Services and Education Appropriations Act
Health Disparities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Reimbursement of diagnostics
H.R. 1625, Vehicle for Consolidated Appropriations Act 2018 FY 2019 Labor, Health and Human Services and Education Appropriations bill
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Trickett Wendier, Frank Morigeiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018, HR 5247, S 204
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
newborn screening, reimbursement of diagnostics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
Direct to Consumer Genetic Testing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · Q1
H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018 FY 2019 Labor, Health and Human Services and Education Appropriations bill
H.R. 1409 Cancer Drug Parity Act of 2017 H.R. 4978 Chronic Disease Management Act of 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4) via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2018 · first_quarter · RR
newborn screening, reimbursement of diagnostics
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Public Law 115-97 AN act to Provide for reconciliation pursuant to Title II and V of the concurrent resolution on the budget for fiscal year 2018 (tax reform)
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Medical Foods
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Health Disparities
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · fourth_quarter · Q4
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act No bill number, Advancing Access to Precision Medicine Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
HR 3358/S 1771, FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Reimbursement of diagnostics HR 3921 Healthy Kids Act S 1827 Keep Kids' Insurance Dependable and Secure Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
Real World Evidence Patient Reported Outcomes Hatch Waxman Amendments to the Food and Drug Cosmetic Act Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · third_quarter · Q3
HR 2810/ S 1519, National Defense Authorization Act
H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 H.R.3354 - Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Regulation of laboratory diagnostics No bill number, Diagnostic Accuracy and Innovation Act
Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
PERSONALIZED MEDICINE COALITION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · 2T
personalized medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Newborn screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Reimbursement of diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Patients' Access to Treatment Act, HR 2999 Biosimilar naming, interchangeability Off Label Communications Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · 2T
FY 2018 Labor, Health and Human Services, Education and related agencies Appropriations Act
Cancer Moonshot Patient Access to lab results
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Direct to consumer genetic testing Regulation and oversight of diagnostics
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · second_quarter · Q2
Labor-HHS-Education Appropriations, FY 2017 and FY 2018 PL 114-223 Continuing Appropriations and Military Construction, Veteran's and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
HR 2810/ S 1519, National Defense Authorization Act
ACA implementation; HR 1409 Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act; Better Care Reconciliation Act; HR 2999 Patients' Access to Treatment Act; S 1045 Save Women's Preventive Care Act; S 689 Invest in Women's Health Act
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Public Law No. 114-255, 21st Century Cures Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Precision Medicine Initiative Regulation of laboratory diagnostics Cancer Moonshot
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Precision Medicine Initiative Regulation of laboratory diagnostics Cancer Moonshot
Public Law No. 114-255, 21st Century Cures Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics HR 1313 Preserving Employee Wellness Program Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Reimbursement of diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS)
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Next generation sequencing based diagnostics
Newborn screening
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Patient's Access to Treatment Act Biosimilar naming, interchangeability Off Label Communications
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Regulation and oversight of diagnostics Reimbursement of diagnostics
FY 2018 Labor, Health and Human Services, Education and Related Agencies Appropriations Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Cancer Moonshot Patient Access to lab results Public Law No. 144-255 21st Century Cures Act
FY 2018 Labor, Health and Human Services, Education and related agencies Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Direct to consumer genetic testing Regulation and oversight of diagnostics S. 2744, Genetic Research Privacy Protection Act Public Law No. 44-255 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
PERSONALIZED MEDICINE COALITION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
personalized medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · Q1
Biosimilars (FDA); ACA implementation; HR 2739/S 1566 - Cancer Drug Coverage Parity Act; HR 1313 Preserving Employee Wellness Programs Act; HR 1628 American Health Care Act
Labor-HHS-Education Appropriations, FY 2017 and FY 2018 PL 114-223 Continuing Appropriations and Military Construction, Veteran's and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PERSONALIZED MEDICINE COALITION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2017 · first_quarter · RR
precision medicine initiative
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Regulation and oversight of diagnostics Cancer Moonshot Reimbursement of diagnostics
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Precision Medicine Initiative Cancer Moonshot Patient Access to lab Results Public Law No. 144-255 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Next generation sequencing based diagnostics
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Direct to consumer genetic testing Regulation and oversight of diagnostics S.2744, Genetic Research Privacy Protection Act Public Law No. 44-255 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation; clinical trials issues (FDA); HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations, FY 2017 PL 114-223 Continuing Appropriations and Military Construction, Veteran's Affairs and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
HR 1600 Patient's Access to Treatment Act Biosimilar naming Patient Engagement with FDA on medical devices Off Label Communications
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · fourth_quarter · Q4
Public Law No. 114-255, 21st Century Cures Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Precision Medicine Initiative Regulation of laboratory diagnostics Cancer Moonshot
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Direct to consumer genetic testing Regulation and oversight of diagnostics Precision Medicine Initiative S.2744, Genetic Research Privacy Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Precision Medicine Initiative Cancer Moonshot Patient Access to lab Results Regulation of Health Software HR 6 21st Century Cures S. 1101 MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
HR 1600 Patient's Access to Treatment Act Biosimilar naming
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation; clinical trials issues (FDA); HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations, FY 2017 PL 114-223 Continuing Appropriations and Military Construction, Veteran's Affairs and related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Next generation sequencing based diagnostics
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
Regulation and oversight of diagnostics Cancer Moonshot Reimbursement of diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · third_quarter · Q3
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Precision Medicine Initiative Regulation of laboratory diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation HR 2739/S 1566 - Cancer Drug Coverage Parity Act
Labor-HHS-Education Appropriations, FY 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Regulation and oversight of diagnostics Cancer Moonshot Reimbursement of diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Precision Medicine Initiative Regulation of laboratory diagnostics Public Law 110-343, Genetic Information Nondiscrimination Act
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 Coverage and reimbursement for molecular diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Precision Medicine Initiative Cancer Moonshot Patient Access to lab Results Regulation of Health Soft Wave HR 6 21st Century Cures S. 1101 MEDTECH Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
HR 1600 Patient's Access to Treatment Act Biosimilar naming arthritis prevention S. 524, Comprehensive Addiction and Recovery Act of 2016 Reimbursement/coverage of arthritis treatment
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Next generation sequencing based diagnostics
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · Q2
Direct to consumer genetic testing Regulation and oversight of diagnostics Precision Medicine Initiative S.2744, Genetic Research Privacy Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
COUNSYL via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · second_quarter · RR
regulation and reimbursement of diagnostics
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Biosimilars - naming (FDA); precision medicine initiative; ACA implementation
Labor-HHS-Education Appropriations, FY 2017
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Direct to consumer genetic testing Regulation and oversight of diagnostics Precision Medicine Initiative
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
HR 1600 Patient's Access to Treatment Act Biosimilar naming arthritis prevention
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ICAHN INSTITUTE FOR GENOMICS AND MULTISCALE BIOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
Next generation sequencing based diagnostics
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2016 · first_quarter · Q1
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Precision Medicine Initiative Regulation of laboratory diagnostics Public Law 110-343, Genetic Information Nondiscrimination Act Federal Policy for the Protection of Human Subject (Common Rule)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
ASSOCIATION FOR MOLECULAR PATHOLOGY via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
HR 6, 21st Century Cure Act Public Law No. 113-93, Protecting Access to Medicare Act of 2014 S. 620/HR. 1189, Preserving Employee Wellness Programs Act
Precision Medicine Initiative Regulation of laboratory diagnostics Public Law 110-343, Genetic Information Nondiscrimination Act Federal Policy for the Protection of Human Subject (Common Rule)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Science & Technology Policy (OSTP), SENATE, White House Office
THYNC, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Regulation of neurological devices
Filing targets: Food & Drug Administration (FDA)
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
HR 1600 Patient's Access to Treatment Act Biosimilar naming
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · fourth_quarter · Q4
Direct to consumer genetic testing Regulation and oversight of diagnostics
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ONYX PHARMACEUTICALS via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · 3A
preventing health disparities
Filing targets: Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH)
SUSAN G. KOMEN via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
HR 2739/S 1566, Cancer Drug Coverage Parity Act HR 1600, Patient's Access to Treatment Act HR 6, 21st Century Cures Act S 620/HR 1189: Preserving Employee Wellness Programs Act S 370/HR 716: Breast Density and Mammography Reporting Act Diagnostic mammography
HR 3020/S 1695, Departments of Labor, HHS & Education and related agencies appropriations, FY2016 HR 2685/S 1558, Department of Defense Appropriations Act, FY2016
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
coverage and reimbursement of laboratory tests
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTHY LIVING FOUNDATION via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
HR 1600 Patient's Access to Treatment Act HR 6, 21st Century Cures Act Biosimilar naming
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Direct to consumer genetic testing HR 6, 21st Century Cures Act Regulation and oversight of diagnostics
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CURE FORWARD via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
Enabling patient access to clinical trials HR 6 21st Century Cures Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVITAE, INC. via CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
2015 · third_quarter · Q3
reimbursement and coverage of genetic tests
Filing targets: Centers For Medicare and Medicaid Services (CMS)
HR 2810/ S 1519, National Defense Authorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACA implementation; HR 1628 American Health Care Act; Better Care Reconciliation Act
tax reform
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE